Reynders McVeigh Capital Management’s Biogen BIIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,850	Closed	-$667K	–	226
2019 Q2	$667K	Sell	2,850 -12,771	-82%	-$2.95M	0.07%	125
2019 Q1	$3.69M	Sell	15,621 -1,588	-9%	-$500K	0.41%	48
2018 Q4	$5.18M	Sell	17,209 -1,275	-7%	-$407K	0.69%	35
2018 Q3	$6.53M	Buy	18,484 +860	+5%	+$296K	0.77%	34
2018 Q2	$5.12M	Buy	17,624 +3,077	+21%	+$865K	0.65%	38
2018 Q1	$3.98M	Buy	14,547 +3,797	+35%	+$1.18M	0.5%	40
2017 Q4	$3.42M	Buy	10,750 +6,075	+130%	+$1.95M	0.45%	46
2017 Q3	$1.46M	Buy	4,675 +3,646	+354%	+$1.08M	0.19%	82
2017 Q2	$279K	Buy	1,029 +20	+2%	+$5.29K	0.04%	184
2017 Q1	$276K	Sell	1,009 -66	-6%	-$18.7K	0.04%	187
2016 Q4	$305K	Sell	1,075 -13	-1%	-$3.85K	0.04%	183
2016 Q3	$341K	Sell	1,088 -186	-15%	-$55.1K	0.05%	168
2016 Q2	$308K	Buy	1,274 +107	+9%	+$28.2K	0.04%	175
2016 Q1	$304K	Buy	1,167 +67	+6%	+$17.7K	0.05%	182
2015 Q4	$337K	Hold	1,100	–	–	0.06%	154
2015 Q3	$321K	Buy	1,100 +425	+63%	+$140K	0.06%	163
2015 Q2	$273K	Buy	+675	New	+$271K	0.04%	174